iHuman Inc. American depositary shares, each representing five Class A ordinary shares (IH)

On our desk, the valuation metrics for iHuman present an interesting paradox. The stock trades at a low market cap of $66 million with a modest P/E ratio of 6.5 and a stellar fundamental value sub-score, but the underlying momentum is severely lagging. Alternative data from AltIndex rates the AI Score at 36 out of 100, highlighting a brand and user growth score of zero. While cash reserves remain exceptionally strong at over RMB1.1 billion, the ongoing multi-year revenue decline from RMB1.01 billion down to RMB807 million in 2025 creates persistent downward pressure that value investors cannot easily ignore.

Reviewing the Form 20-F filings and latest financial updates, the structural risks tied to the Cayman Islands holding company model and mainland China operations remain a critical overhang for IH. Even though net income held relatively steady at RMB95.4 million for fiscal year 2025 through aggressive cost-cutting, active user metrics continue to contract, with average total MAUs sliding from 26.51 million down to 23.62 million in Q1 2026. Until we see a reliable inflection point in top-line growth or user engagement, passive holding carries considerable structural volatility.

Watching the technical footprint and upcoming catalysts heading into the September 16 earnings print, our quantitative models label the technical read at a weak 2.10 out of 10, categorizing it as underperforming. Although market sentiment via institutional fund flows scores surprisingly well at 8.39, the broader trend shows a 24.2% drop over the last three months down to $1.25 per share. Analysts modeling the upcoming print should focus heavily on whether operating expenses can offset further expected contractions in gross profit.